Wolfgang Jungraithmayr | Medicine and Dentistry | Lifetime Achievement Award

Posted on by Phenomenological Research

Lifetime Achievement Award

Wolfgang Jungraithmayr
University Hospital of Rostock, Germany

Wolfgang Jungraithmayr
Researcher Wolfgang Jungraithmayr
Affiliation University Hospital of Rostock
Country Germany
Scopus ID 25621008100
Documents 129
Citations 2,929
h-index 28
Subject Area Medicine and Dentistry
Event International Phenomenological Research Awards
ORCID 0000-0002-1442-4862

Wolfgang Jungraithmayr, MD, PhD, is a German thoracic surgeon, clinician-scientist, educator, and academic leader serving as Chair and Full Professor of Thoracic Surgery at the University Hospital of Rostock. His research portfolio spans lung transplantation, thoracic oncology, immunology, translational medicine, and experimental surgery. He is particularly recognized for pioneering the orthotopic mouse lung transplantation model and for advancing translational research into lung cancer immunotherapy and transplant immunology.[1]

Abstract

This article evaluates the scholarly achievements, research leadership, educational contributions, and international influence of Wolfgang Jungraithmayr in the fields of thoracic surgery, lung transplantation, and translational oncology. His work integrates clinical practice with experimental science, contributing to advances in transplant immunology, lung cancer therapeutics, and surgical innovation. Through sustained research productivity, competitive grant acquisition, international collaboration, and extensive scientific mentorship, he has established a distinguished academic profile suitable for consideration for lifetime recognition within the biomedical sciences.[1]

Keywords

Thoracic Surgery; Lung Transplantation; Lung Cancer; Immunology; Translational Medicine; CD26; Experimental Surgery; Academic Leadership; Oncology; Lifetime Achievement.

Introduction

Wolfgang Jungraithmayr has developed an interdisciplinary academic career combining thoracic surgical practice, translational biomedical research, and university-level education. Following medical training in Germany and advanced specialization in Switzerland, he completed doctoral research in immunology at the University and ETH Zurich. His subsequent appointments included leadership positions at the University Hospital Zurich, Medical University Brandenburg, and University Hospital Rostock, where he currently serves as Chair of Thoracic Surgery.[2]

His scientific activities have focused on improving outcomes in lung transplantation, understanding immune-mediated disease mechanisms, and identifying novel therapeutic targets for thoracic malignancies. These efforts have produced a substantial body of peer-reviewed literature and attracted significant competitive funding from European research agencies.[1]

Research Profile

Wolfgang Jungraithmayr’s research program centers on lung transplantation biology, transplant tolerance, tumour immunology, and translational thoracic oncology. A major contribution of his laboratory has been the establishment and dissemination of the orthotopic mouse lung transplantation model, which has become a valuable experimental platform for investigating immune responses, rejection mechanisms, and therapeutic interventions across multiple disciplines.[3]

His laboratory has secured more than €3.2 million in competitive research funding, including support from the German Research Foundation (DFG), Swiss National Science Foundation (SNSF), and other major funding bodies. Research projects have addressed chronic lung allograft dysfunction, immune regulation, magnetic resonance imaging applications, angiogenesis, and targeted immunotherapeutic approaches against lung adenocarcinoma.[1]

Research Contributions

Wolfgang Jungraithmayr’s principal research contributions include pioneering murine lung transplantation models, advancing transplant immunology, investigating immune tolerance mechanisms, identifying novel therapeutic targets in lung cancer, and improving understanding of ischemia-reperfusion injury and chronic allograft dysfunction.[2][4][5][6]

Publications

Recent publications highlight Jungraithmayr’s contributions to transplantation immunology, lung transplant outcomes, ischemia-reperfusion injury, and experimental models of chronic allograft dysfunction, demonstrating sustained impact in thoracic surgery and translational research.[2][3][4][5][6]

Wolfgang Jungraithmayr has authored more than 160 scientific publications and maintains a sustained record of peer-reviewed research. Representative publications reflect his contributions to lung transplantation, transplant immunology, and thoracic oncology.[1]

Research Impact

According to Scopus metrics, Jungraithmayr has accumulated 129 indexed documents, 2,929 citations, and an h-index of 28. These indicators demonstrate sustained scholarly influence within thoracic surgery, transplantation science, and oncology research.[1]

Beyond publication metrics, his impact is reflected through international teaching initiatives, reviewer responsibilities for leading journals, grant-review service for major funding agencies, editorial board memberships, and mentorship of emerging clinicians and scientists. His laboratory has trained investigators from numerous institutions across Europe, North America, and Asia, thereby extending the global reach of his methodological innovations.[1]

Award Suitability

Several factors support consideration of Wolfgang Jungraithmayr for a Lifetime Achievement Award. These include his longstanding record of scientific productivity, leadership of internationally recognized research programs, establishment of innovative experimental models, successful acquisition of competitive funding, extensive educational activities, and receipt of numerous international scientific distinctions. His contributions have influenced both clinical practice and experimental biomedical research, particularly in thoracic surgery and transplantation science.[1]

The cumulative scope of his achievements illustrates a sustained commitment to advancing medical knowledge, supporting scientific collaboration, and fostering the development of future generations of clinician-scientists.[2]

Conclusion

Wolfgang Jungraithmayr represents a notable figure in contemporary thoracic surgery and translational medicine. Through pioneering research, academic leadership, international educational engagement, and sustained scientific productivity, he has contributed significantly to the advancement of lung transplantation and thoracic oncology. His record of achievement, influence, and service provides a strong basis for recognition within the framework of a Lifetime Achievement Award.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Wolfgang Jungraithmayr, Author ID 25621008100. Scopus. https://www.scopus.com/authid/detail.uri?authorId=25621008100
  2. Ohm B, Giannou AD, Harriman DI, Jungraithmayr WM, Zazara DE, et al. (2025). Chimerism and Immunological Tolerance in Solid Organ Transplantation. Immunologic Research. https://link.springer.com/article/10.1007/s00281-025-01052-x
  3. Moneke I, Ogutur ED, Kornyeva A, Jungraithmayr WM, Frye BC, et al. (2024). Donor Age Over 55 Is Associated With Worse Outcome in Lung Transplant Recipients With Idiopathic Pulmonary Fibrosis. BMC Pulmonary Medicine, 2024. https://link.springer.com/article/10.1186/s12890-024-03317-x
  4. Sander ML, Eulenburg V, Maeyashiki T, Jungraithmayr WM, Piegeler T, et al. (2024). Remote Kidney and Liver Injury After Transplantation of Lung Allografts in an Allogeneic Mouse Model. Transplantation Proceedings, 2024. DOI: https://doi.org/10.1016/j.transproceed.2024.10.020
  5. Coppens A, Verleden SE, Claes E, Voet H, Verleden GM, Lapperre TS, Yildirim AÖ, et al. (2024). Murine Orthotopic Lung Transplant Models: A Comprehensive Overview of Genetic Mismatch Degrees and Histopathological Insights Into Chronic Lung Allograft Dysfunction. American Journal of Transplantation, 2024. DOI: https://doi.org/10.1016/j.ajt.2024.07.033
  6. Jungraithmayr W. (2020). Novel Strategies for Endothelial Preservation in Lung Transplant Ischemia-Reperfusion Injury. Frontiers in Physiology, 2020. DOI: https://doi.org/10.3389/fphys.2020.581420

Makhotso Merriam Ralehike | Nursing and Health Professions | Innovative Research Award

Posted on by Phenomenological Research

Innovative Research Award

Makhotso Merriam Ralehike – University of Pretoria, South Africa

Makhotso Merriam Ralehike
Affiliation University of Pretoria
Country South Africa
ORCID 0009-0009-2006-366X
Document 1
Subject Area Nursing and Health Professions
Event International Phenomenological Research Awards

Makhotso Merriam Ralehike is a South African nursing professional, occupational health practitioner, nurse educator, and bioethics specialist affiliated with the University of Pretoria. Her academic and professional activities focus on occupational health, nursing ethics, healthcare quality, rural health systems, patient safety, and evidence-based nursing practice. Through clinical service, educational leadership, and emerging scholarly contributions, she has developed expertise relevant to contemporary healthcare challenges and nursing policy development.[1]

Abstract

Makhotso Merriam Ralehike has developed a multidisciplinary professional profile integrating nursing practice, occupational health, healthcare ethics, education, and rural healthcare research. Her work addresses healthcare quality, workforce wellbeing, patient safety, and ethical challenges within resource-constrained environments. Her published research on nurses’ experiences in water-scarce healthcare clinics contributes to understanding healthcare delivery challenges in South Africa and supports evidence-informed policy and professional practice improvements.[2]

Keywords

Nursing Science, Occupational Health Nursing, Bioethics, Rural Healthcare, Healthcare Quality, Patient Safety, Nursing Education, Evidence-Based Practice, Health Policy, Clinical Leadership.

Introduction

The nursing profession increasingly requires practitioners who combine clinical expertise with ethical leadership, occupational health knowledge, educational competence, and research engagement. Ralehike’s professional development reflects this interdisciplinary approach through service in critical care, occupational health, nursing education, and healthcare management. Her academic progression includes advanced qualifications in nursing education, labour law, disaster management, HIV and TB management, occupational health nursing, and bioethics, supporting a broad perspective on healthcare systems and workforce development.[1][2]

Research Profile

As a PhD candidate in Nursing Science at the University of Pretoria, Makhotso Merriam Ralehike focuses on nursing ethics, occupational health, healthcare quality, rural health systems, and patient-centered care. Her academic interests emphasize ethical responsibilities within healthcare environments, particularly where infrastructure limitations influence professional practice and patient outcomes. Her educational background provides a foundation for examining healthcare challenges through clinical, legal, ethical, and organizational perspectives.[1]

Research Contributions

Makhotso Merriam Ralehike’s principal scholarly contribution investigates the lived experiences of nurses working in healthcare clinics affected by water scarcity within the Maluti-A-Phofung district of South Africa. The study explores how environmental and infrastructural limitations affect healthcare delivery, professional obligations, and patient care standards. By documenting frontline nursing experiences, the research contributes evidence relevant to healthcare planning, nursing regulation, occupational wellbeing, and service quality improvement initiatives.[2]

Publications

Makhotso Merriam Ralehike’s most significant publication examines nurses’ lived experiences within healthcare clinics experiencing water scarcity in South Africa’s Free State Province. The study highlights ethical responsibilities, operational challenges, healthcare quality concerns, and workforce resilience in resource-constrained settings while providing evidence relevant to nursing policy, occupational health, healthcare infrastructure planning, and patient safety improvements across underserved communities.[2]

Research Impact

The practical relevance of Ralehike’s research lies in its focus on real-world healthcare challenges affecting nurses and patients in rural and resource-limited environments. Her work contributes to broader discussions concerning healthcare equity, workplace conditions, ethical accountability, and sustainable healthcare delivery. Such evidence supports policymakers, healthcare managers, educators, and practitioners seeking improvements in healthcare infrastructure and service provision.[2]

Award Suitability

Makhotso Merriam Ralehike demonstrates attributes aligned with recognition under the International Phenomenological Research Awards through her investigation of lived professional experiences in healthcare settings. Her interdisciplinary expertise spanning nursing science, occupational health, ethics, and education supports research that addresses human experiences within complex healthcare environments. The phenomenological orientation of her published work and its relevance to healthcare practice, policy, and professional wellbeing provide a strong basis for consideration within research recognition initiatives.[2]

Conclusion

Makhotso Merriam Ralehike represents an emerging nursing scholar whose professional experience, advanced academic preparation, and healthcare research collectively contribute to nursing science and occupational health practice. Her focus on ethical healthcare delivery and lived experiences within resource-constrained clinical environments supports ongoing efforts to improve healthcare quality, workforce wellbeing, and evidence-based policy development in South Africa.[1][2]

References

  1. ORCID. (n.d.). Makhotso Merriam Ralehike – ORCID Profile. https://orcid.org/0009-0009-2006-366X
  2. Ralehike, M.M., Mulaudzi, M.F., Sepeng, N.V., & Nyandeni, S. (2026). Lived experience of nurses working in healthcare clinics that are experiencing water scarcity, in Maluti-A-Phofung district, Free State Province, South Africa. International Journal of Africa Nursing Sciences. DOI: https://doi.org/10.1016/j.ijans.2026.101114

Qizhi Diao | Medicine and Dentistry | Research Excellence Award

Posted on by Phenomenological Research

Research Excellence Award

Qizhi Diao
Hainan Branch, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, China
Qizhi Diao
Affiliation Shanghai Jiao Tong University
Country China
Designation Professor
Scopus ID 52563308500
Documents 19
Citations 252
h-index 9
Subject Area Medicine and Dentistry
Event International Phenomenological Research Awards
ORCID 0000-0003-1121-4656

Qizhi Diao is a professor affiliated with the Hainan Branch of Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Sanya, China. His academic work has focused on the synthesis of functional nanomaterials, the construction of advanced clinical diagnostic sensors, and the development of nanocarrier-mediated therapeutic systems for biomedical applications. His research activities have contributed to innovations in biosensing technologies, point-of-care diagnostics, CRISPR/Cas-enabled sensing systems, and nanopharmaceutical delivery platforms.[1] Diao has participated in multiple nationally and provincially funded scientific projects related to cancer diagnostics, SARS-CoV-2 detection technologies, and exosome identification systems within nucleic acid assembly frameworks.[2]

Abstract

The academic contributions of Qizhi Diao are associated with interdisciplinary developments in nanomedicine, biosensor engineering, and clinical laboratory technologies. His research has emphasized the design of graphdiyne-based nanostructures, electrochemical sensing systems, nanozyme-assisted diagnostics, and portable point-of-care biosensing platforms. Through projects supported by the National Natural Science Foundation of China and regional scientific agencies, Diao has contributed to the development of technologies for detecting infectious diseases, circulating tumor cells, and gastric cancer biomarkers.[3] His work integrates materials science, clinical diagnostics, and biomedical engineering into translational research frameworks applicable to modern laboratory medicine.

Keywords

Nanomaterials; Graphdiyne; Clinical Diagnostic Sensors; CRISPR/Cas Technology; Electrochemical Biosensors; Nanopharmaceuticals; Targeted Drug Delivery; Nanozymes; Medical Laboratory Technology; Point-of-Care Diagnostics; Biomedical Engineering; Electrochemical Sensing.

Introduction

Recent advancements in biomedical engineering and nanotechnology have accelerated the development of highly sensitive diagnostic platforms and targeted therapeutic systems. Within this scientific context, Qizhi Diao has conducted research aimed at integrating nanomaterial synthesis with clinical laboratory applications. His work has addressed major challenges in biosensing accuracy, rapid pathogen detection, and nanocarrier-mediated therapeutic delivery systems.[4]

Qizhi Diao’s investigations into graphdiyne-based sensing systems and nanozyme catalytic materials have contributed to the broader understanding of electrochemical diagnostics and biosensor miniaturization. His projects have also focused on CRISPR/Cas-mediated detection systems capable of improving diagnostic sensitivity for infectious diseases and cancer-associated biomarkers.[5]

Research Profile

Qizhi Diao has maintained a long-term academic focus on the fabrication of functional nanomaterials, clinical diagnostic sensors, and nanocarrier-mediated drug delivery systems. His institutional affiliations include the Hainan Branch of Shanghai Children’s Medical Center and Shanghai Jiao Tong University School of Medicine.[1]

His completed and ongoing projects include:

  • Research on encoding for the identification of plasma exosome subtypes based on confined recognition and amplification systems within nucleic acid assembly frameworks funded by the National Natural Science Foundation of China.
  • Portable sensors for simultaneous detection of multiple gastric cancer biomarkers using CRISPR/Cas technology funded by the Hainan Provincial Health Commission.
  • Point-of-care quantitative detection systems for SARS-CoV-2 nucleic acids using graphdiyne sub-nanosheets supported by the Natural Science Foundation Project of Chongqing.
  • Novel 3D magnetic nanocomposites based on graphdiyne-MOFs for simultaneous capture and chemotherapy of circulating tumor cells in peripheral blood.
  • Development of graphdiyne-based systems for the detection of SARS-CoV-2 antigen biomarkers under emergency biomedical research initiatives.

His scientific profile additionally includes responsibilities as an ISO 15189 medical laboratory accreditation assessor and research review expert for multiple scientific organizations and governmental institutions in China.[6]

Research Contributions

Among Qizhi Diao’s reported scientific contributions is the synthesis of sub-nanoscale graphdiyne materials for the rapid and quantitative detection of Mycobacterium tuberculosis and drug-resistant genes.[7] This work supported the development of fluorescence sensing systems with improved analytical sensitivity and operational simplicity.

He also contributed to the preparation of core-shell nanozymes such as ZrFe-MOF@PtSn exhibiting strong peroxidase-like catalytic properties for biosensing applications. Additionally, his research integrated miRNA-initiated strand displacement amplification with CRISPR/Cas12a amplification strategies, nanozyme catalysis, and machine-learning-assisted electrochemical sensing systems.[8]

Qizhi Diao has further contributed to patents related to electrochemical immunosensors, medical testing oscillation devices, and laboratory inspection equipment. These developments reflect the translational dimension of his work in clinical laboratory technologies.[9]

Publications

Qizhi Diao has published research in internationally recognized journals focusing on nanotechnology, biomedical sensing, and clinical diagnostic systems. His publications explore graphdiyne-based fluorescent sensing platforms for detecting Mycobacterium tuberculosis and drug-resistant genes, nanoparticle-based drug delivery systems for cardiovascular diseases, and nanozyme-assisted biosensing technologies for rapid pathogen detection. He has also contributed to studies on high-porosity carbon electrocatalysts and amino-functionalized carbon nanodots for biomedical applications. His scholarly work integrates nanomaterials, electrochemical sensing, CRISPR/Cas technologies, and translational laboratory medicine, supporting advancements in point-of-care diagnostics, targeted therapeutics, and innovative clinical biosensor development.

Research Impact

The research activities of Qizhi Diao have contributed to interdisciplinary developments linking nanotechnology, laboratory medicine, and biomedical sensing systems. His work on graphdiyne nanostructures and nanozyme catalytic platforms has been associated with improved biosensor sensitivity and enhanced diagnostic performance in infectious disease detection.[10]

According to the provided academic indicators, his research record includes an h-index of 9 and more than 252 citations indexed through Scopus, in addition to reported Web of Science citations exceeding 300.[11] His collaborative work with organizations such as the Chinese Medical Doctor Association and the Chinese Medical Association has also supported laboratory medicine standardization and diagnostic research initiatives.

Award Suitability

The academic profile of Qizhi Diao demonstrates sustained engagement in translational biomedical research, particularly within nanomaterials, biosensors, and clinical diagnostics. His involvement in nationally funded scientific projects, patented technologies, and peer-reviewed publications indicates an active contribution to applied medical research and laboratory innovation.

His combination of scientific output, technical expertise, research leadership, and participation in accreditation and evaluation activities supports consideration for the Research Excellence Award under the International Phenomenological Research Awards framework.

Conclusion

Qizhi Diao has contributed to the advancement of nanotechnology-enabled diagnostic systems and biomedical sensing platforms through interdisciplinary scientific research. His work combines materials engineering, electrochemical sensing, nanozyme catalysis, and clinical laboratory applications into translational biomedical solutions. Through publications, funded research projects, patents, and scientific service roles, he has established a research profile connected to contemporary developments in medical diagnostics and nanomedicine.

References

  1. International Phenomenological Research Awards. (2026). Award nomination application form: Qizhi Diao. https://phenomenologicalresearch.com/
  2. National Natural Science Foundation of China. Research project information related to biomedical sensing and exosome identification systems.
  3. Diao Q. Research projects and biomedical sensing technologies associated with clinical diagnostics and nanomaterials research.
  4. Shanghai Jiao Tong University School of Medicine. Biomedical nanotechnology and laboratory medicine research activities.
  5. CRISPR/Cas biosensing applications in rapid diagnostic systems and molecular detection technologies.
  6. China National Accreditation Service for Conformity Assessment (CNAS). ISO 15189 medical laboratory accreditation activities and technical assessment programs.
  7. Chang F, Huang L, Guo C, Xie G, Li J, Diao Q. (2019). Graphdiyne-Based One-Step DNA Fluorescent Sensing Platform for the Detection of Mycobacterium tuberculosis and Its Drug-Resistant Genes. ACS Applied Materials & Interfaces. https://pubs.acs.org/doi/abs/10.1021/acsami.9b15248
  8. Yang F, Xue J, Wang G, Diao Q. (2022). Nanoparticle-based drug delivery systems for the treatment of cardiovascular diseases. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.999404
  9. Chinese patent documentation related to electrochemical immunosensors, laboratory inspection devices, and medical testing technologies.
  10. Feng T, Liao W, Li Z, Sun L, Shi D, Guo C, Huang Y, Wang Y, Cheng J, Li Y, Diao Q. (2017). Heavily Graphitic-Nitrogen Self-doped High-porosity Carbon for the Electrocatalysis of Oxygen Reduction Reaction. Nanoscale Research Letters. https://link.springer.com/article/10.1186/s11671-017-2364-6
  11. Elsevier. (n.d.). Scopus author details: Qizhi Diao, Author ID 52563308500. Scopus. https://www.scopus.com/authid/detail.uri?authorId=52563308500

Dr. Elena Tchetina | Medicine and Dentistry | Excellence in Research Award

Posted on by Phenomenological Research

Dr. Elena Tchetina | Medicine and Dentistry | Excellence in Research  Award 

Leading Scientist at Nasonova Research Institute of Rheumatology | Russia

Dr. Elena Tchetina is a distinguished researcher in medicine and dentistry, recognized for her impactful contributions to molecular biology and rheumatology. Her academic foundation includes advanced training in microbiology, cell biology, and molecular sciences, supporting a strong interdisciplinary approach to biomedical research. She has extensive experience as a leading scientist and principal investigator, contributing to high-level research in immunology and molecular physiology. Her research interests focus on osteoarthritis, rheumatoid arthritis, and osteoporosis, with emphasis on gene expression, metabolic regulation, and biomarker discovery for disease progression and therapeutic response. Dr. Elena Tchetina has produced 53 documents with an h-index of 18 and has received 8,094 citations across 7,863 documents, reflecting her global research influence. Her work advances translational medicine by connecting molecular insights with clinical applications, strengthening innovative strategies for diagnosis, prognosis, and personalized treatment in rheumatic diseases.

Citation Metrics

8000

7000

6000

5000

4000

Citations
8094

Documents
53

h-index
18

View Scopus ProfileView ORCID Record

Featured Publications

Molecular Mechanisms of Osteoarthritis Progression and Cartilage Degeneration

– International Journal of Molecular Sciences

Gene Expression Signatures in Rheumatoid Arthritis and Therapeutic Targets

– Frontiers in Immunology

Biomarkers for Predicting Disease Progression in Osteoarthritis Patients

– Arthritis Research & Therapy

Metabolic Pathways and Inflammation in Joint Disorders

– Journal of Clinical Medicine

Translational Approaches in Rheumatology: From Molecular Insights to Clinical Practice

– Clinical Rheumatology

Franziska Münz | Medicine and Dentistry | Future Science Leader Award

Posted on by Phenomenological Research

Dr. Franziska Münz | Medicine and Dentistry | Future Science Leader Award 

Physician at Universität Heidelberg | Germany

Dr. Franziska Münz is a promising researcher in the field of Medicine and Dentistry, demonstrating strong scientific impact through 10 scholarly documents that have collectively received 97 citations across 88 academic works, alongside an h-index of 5. Her research contributions focus on advancing medical knowledge through evidence-based approaches, particularly in clinically relevant and translational domains. Her work reflects a commitment to improving healthcare outcomes by exploring innovative methodologies and interdisciplinary perspectives. With a growing citation record and consistent publication output, Dr. Franziska Münz shows clear potential as an emerging leader in future scientific advancements. Her research trajectory highlights both quality and influence, positioning her as a valuable contributor to the global medical research community and a strong candidate for recognition under the Future Science Leader Award.

Citation Metrics

100

75

50

25

0

Citations
97

Documents
10

h-index
5

View Scopus Profile

Top 5 Publications

Bing Han | Medicine and Dentistry | Outstanding Scientist Award

Posted on by Phenomenological Research

Dr.Bing Han | Medicine and Dentistry | Outstanding Scientist Award 

Dermatologist at The First Hospital of Jilin University | China

Dr. Bing Han is a medical researcher and clinician specializing in dermatological science with a strong foundation in advanced medical education and academic training. Dr. Bing Han has extensive professional experience integrating clinical practice with translational research, focusing on melanoma, vitiligo, and molecular mechanisms of skin disease progression. The research interests emphasize biomarker discovery, metabolic reprogramming, and therapeutic innovation in dermatology. With 99 scholarly documents, 1,291 citations from 1,231 documents, and an h-index of 22, Dr. Bing Han demonstrates sustained scientific impact and excellence in medical research.

Citation Metrics (Scopus)

1400

1000

600

200

0

Citations
1,291

Documents
99

h-index
22


View Scopus Profile

Featured Publications

Taeyoung Kyong | Medicine and Dentistry | Research Excellence Award

Posted on by Phenomenological Research

Dr. Taeyoung Kyong | Medicine and Dentistry | Research Excellence Award 

Professor at Yonsei University College of Medicine | South Korea

Dr. Taeyoung Kyong is a medical academic and clinician recognized for expertise in hospital medicine and inpatient care. His education and professional training underpin a strong foundation in internal medicine and clinical research. He has extensive experience integrating patient-centered practice with system-based healthcare improvement. His research interests focus on hospitalist-led care models, diabetes management, quality improvement, and digital health applications. Overall, Dr. Taeyoung Kyong’s work reflects a sustained commitment to advancing evidence-based inpatient medicine and healthcare excellence.

View ORCID

Featured Publications

Rolf Teschke | Medicine and Dentistry | Best Paper Award

Posted on by Phenomenological Research

Prof. Rolf Teschke | Medicine and Dentistry | Best Paper Award

Professor at Klinikum Hanau | Germany

Prof. Rolf Teschke is an internationally recognized expert in hepatology whose distinguished career has significantly influenced contemporary understanding of liver diseases, hepatotoxicity, and drug-induced liver injury. Educated at leading medical institutions and trained in internal medicine with specialization in gastroenterology and hepatology, he advanced early in his career through rigorous scientific and clinical environments that shaped his enduring interest in hepatic metabolism and toxicology. His research journey includes extensive work in experimental hepatology, where he contributed pivotal insights into microsomal ethanol-oxidizing systems, cytochrome P450 related pathways, and the biochemical mechanisms underlying alcohol-associated and toxin-induced liver damage. Over several decades, Prof. Rolf Teschke has held prominent academic and clinical positions, leading major medical departments and contributing to both patient care and research innovation. His expertise is particularly well known for advancing causality assessment methodologies in drug-induced liver injury, especially through his influential work with the RUCAM system, which has become a globally referenced tool in hepatotoxicity evaluation. Throughout his career, he has produced a substantial body of peer-reviewed literature, reflecting profound scientific productivity and impact. His publication record includes 171 documents, supported by 6,888 citations across 4,040 citing documents, and an impressive h-index of 48, underscoring the depth, relevance, and international recognition of his work. Prof. Rolf Teschke’s research interests span alcoholic liver disease, herbal and drug hepatotoxicity, biochemical enzymology, and clinical hepatology, integrating laboratory discoveries with real-world clinical applications to improve diagnostic standards and therapeutic strategies. He has authored and co-authored more than 250 publications, including articles, book chapters, and comprehensive reviews, contributing to foundational knowledge used by clinicians, toxicologists, and regulatory bodies worldwide. In addition to research, he has served in editorial roles for several journals, helping guide scientific discourse in hepatology and liver toxicology. Overall, Prof. Rolf Teschke’s career reflects a sustained commitment to advancing scientific excellence, improving patient outcomes, and shaping global best practices in the study of liver injury, marking him as one of the leading contributors to modern hepatology.

Profile; Scopus | Orcid

Featured Publications:

Teschke, R. Drug-Induced Autoimmune Hepatitis by Varenicline and Infliximab as a Continuous Disease Spectrum with Two Different Flares: Acute Liver Injury Followed by Hepatic Autoimmunity. Review.
Annotation: Discusses two-step autoimmune hepatitis triggered by pharmaceutical agents, highlighting diagnostic and clinical implications.

Teschke, R. Acute Liver Failure with Determinate rather than Indeterminate Etiology Facilitates Therapy and May Avoid Liver Transplantation: A Critical Analysis. Review.
Annotation: Evaluates clinical outcomes in acute liver failure and argues the benefits of precise etiological identification.

Teschke, R., et al. Drug-Induced Autoimmune Hepatitis: Robust Causality Assessment Using Two Different Validated and Scoring Diagnostic Algorithms. Review.
Annotation: Compares two validated diagnostic algorithms to strengthen causality assessment in drug-induced autoimmune hepatitis.

Teschke, R. Immunology Highlights of Four Major Idiosyncratic DILI Subtypes Verified by the RUCAM: A New Evidence-Based Classification. Review.
Annotation: Proposes an evidence-based immunological classification for idiosyncratic drug-induced liver injury (DILI).

Teschke, R., et al. Metabolic Mysteries of Copper Dysregulation in Wilson Disease. Review.
Annotation: Explores metabolic pathways and unresolved mechanisms underlying copper dysregulation in Wilson’s disease.

Teschke, R., et al. Open Questions on How Metabolic Dysfunction-Associated Steatotic Liver Disease Shapes the Course of Drug-Induced Liver Injury. Letter.
Annotation: Raises key unresolved scientific and clinical questions on the interaction between MASLD and DILI.

Teschke, R. Liver Injury in Immune Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Five New Classification Types. Review.
Annotation: Introduces a new five-type classification system for liver injury associated with severe immune-mediated skin reactions.

Teschke, R. Acute Liver Failure Due to Assumed Drug Induced Liver Injury but Lack of Any Validated Causality Algorithm: Evidence by 36 Cohort Reports with 21,709 Cases. Review.
Annotation: Critically analyzes large cohorts revealing gaps in validated causality assessment for assumed DILI-related acute liver failure.

Teschke, R. Idiosyncratic Hepatocellular Drug-Induced Liver Injury by Flucloxacillin with Evidence Based on RUCAM and HLA B57:01 Genotype.* Review.
Annotation: Examines metabolic and immune mechanisms underlying flucloxacillin-induced hepatocellular injury.

Teschke, R., et al. Successful Corticosteroid Therapy for Severe Liver Injury Secondary to Herbal Traditional Chinese Medicine Mega Defends X: A Case Report. Article, 2024.
Annotation: Documents a clinically significant case showing steroid responsiveness in herb-induced liver injury assessed by updated RUCAM.

Serap Ozdemir | Nursing and Health Professions | Best Researcher Award

Posted on by Phenomenological Research

Dr. Serap Ozdemir | Nursing and Health Professions | Best Researcher Award

Assistant Professor at Gaziantep University | Turkey

Dr. Serap Özdemir is a dedicated and forward-thinking academic whose contributions to nursing and health professions reflect a continuous commitment to advancing evidence-based pediatric and neonatal care. With a strong educational foundation culminating in doctoral-level training in child health and disease nursing, she has built a research portfolio focused on enhancing clinical outcomes for newborns, preterm infants, and children within diverse healthcare settings. Her professional experience includes teaching, academic leadership, and active involvement in multidisciplinary research collaborations that integrate nursing expertise with emerging scientific and technological innovations. Over the course of her academic career, nominee Dr. Serap Özdemir has developed a growing publication record consisting of 16 scholarly documents that have collectively earned 44 citations by 43 external publications, contributing to an h-index of 3 and demonstrating measurable influence within her field. Her research interests encompass neonatal intensive care, developmental health, the improvement of comfort and stress parameters in early infancy, and the application of modern data-driven tools such as artificial intelligence to clinical assessment and decision-making. She has taken part in multiple randomized controlled studies and instrument development projects designed to enhance the measurement of nursing performance, care quality, and professional competency in pediatric nursing environments. Her scientific output extends to peer-reviewed journals indexed in major research databases, as well as contributions to academic books and professional texts that support the dissemination of current best practices to nursing practitioners and students. Additionally, her work reflects a commitment to international engagement through collaborations, conference participation, and involvement in professional associations supporting knowledge exchange and healthcare improvement. Through these combined efforts, Dr. Serap Özdemir continues to shape contemporary thinking around neonatal and pediatric care, promoting research-driven nursing standards that emphasize compassionate, culturally sensitive, and scientifically validated interventions. She remains devoted to advancing healthcare delivery through continuous scholarship, the refinement of clinical methodologies, and the pursuit of innovative interdisciplinary solutions that support improved outcomes for vulnerable patient populations. Her ongoing work reinforces the essential role of nursing research in improving health systems globally and contributes meaningfully to the development of a more advanced, responsive, and patient-centered model of pediatric and neonatal care.

Profile: Scopus | Google Scholar

Featured Publicaations:

Özdemir, S., & Balcı, S. (2024). The effect of tub bathing on the skin and bilirubin levels of babies receiving tunnel and light-emitting diode phototherapies: A randomized controlled trial. Advances in Skin and Wound Care, 37(7), 1–9.

Özdemir, S., & Elmaoğlu, E. (2024). Psychometric properties of the pediatric ward nurses’ caring self-efficacy scale: A Turkish validity and reliability study. Journal of Pediatric Nursing, 75, 41–48.

Özdemir, S., & Küçük, F. (2023). The effect of the facilitated tucking after vaginal delivery on stress, comfort, and physiological parameters of late preterm infants: A randomized controlled trial. Iranian Journal of Neonatology, 14(4), 12–20.

Özdemir, S., & Sevinç, S. (2023). Correlation between cultural competence, xenophobia, and attitudes towards brain drain in nursing students. Nurse Education Today, 131, Article 105963.

Özdemir, S., & Elmaoğlu, E. (2023). Validity and reliability of the distracting ingenuity promotion scale in pediatric nurses. HUHEMFAD-JOHUFON, 10(3), 230–236.

Özdemir, S. (2022). Design of autonomous controlled integrated system for increasing comfort in newborns: Interdisciplinary collaboration between engineering and nursing studies. Dentistry & Medical Research, 8(2), 2–6.

Özdemir, S. (2022). Interdisciplinary collaboration between engineering and nursing: Baby crying analyzing using MATLAB graphical user interface. Biomed Biotechnology Research Journal, 6(3), 410–415.

Özdemir, S., & Yılmaz E. Ç. (2022). Interdisciplinary collaboration between engineering and nursing on baby crying analyzing and classification: A biotechnology study. Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, 1(2), 82–87.

Cristina Maria Del Prete | Medicine and Dentistry | Women Researcher Award

Posted on by Phenomenological Research

Dr. Cristina Maria Del Prete | Medicine and Dentistry | Women Researcher Award 

Rehabilitation Department Chair at Local Health Authority Italy

Dr. Cristina Maria Del Prete is a recognized professional in the field of Physical and Rehabilitation Medicine, known for her commitment to advancing innovative healthcare models, interdisciplinary rehabilitation practices, and measurable improvements in patient quality of life. She completed comprehensive medical education and specialized training in rehabilitation medicine, followed by multiple advanced executive and managerial qualifications focused on healthcare systems, organizational leadership, digital transformation, and strategic management. Her education laid a strong foundation for a career that has spanned clinical practice, healthcare administration, academic teaching, and national health policy participation. Over the years, she has held progressive leadership roles within major public healthcare structures, directing rehabilitation departments, coordinating multidisciplinary teams, and overseeing complex service networks involving hospital- and community-based rehabilitation centers. Her responsibilities have included workforce management, budget oversight, strengthening patient-care pathways, improving standards of disability support, and enhancing regional service delivery in alignment with evolving healthcare regulations. She has also actively contributed to national and regional scientific boards, steering committees, and professional societies focused on improving spasticity management, supporting patients with neurological conditions, addressing musculoskeletal pain, and advancing gender-inclusive perspectives within modern healthcare. Her research output reflects a strong blend of clinical relevance and academic rigor, focusing on post-stroke rehabilitation, botulinum toxin interventions in neuromotor disorders, gait analysis, scoliosis management, family coping mechanisms in the context of disability, and the psychological dynamics influencing care outcomes. Her published studies in international peer-reviewed journals demonstrate a dedication to evidence-based rehabilitation, resulting in 63 citations from 55 documents, 7 published scientific works, and an h-index of 4. She has also contributed extensively to academic progress through university teaching appointments across multiple medical programs, where she has trained students in foundational and advanced principles of rehabilitation medicine. International clinical training and professional development programs have further enhanced her expertise and broadened her exposure to advanced rehabilitative technologies, patient-centered methodologies, and global best practices. Throughout her career, she has remained consistently committed to improving health system performance, innovating care delivery frameworks, and conducting research that informs more efficient, equitable, and clinically effective rehabilitation services. Her professional journey reflects a continuous dedication to advancing healthcare quality, supporting both patients and practitioners, and strengthening the scientific foundations of modern rehabilitation.

Profile: Scopus | Google Scholar

Featured Publications:

Del Prete, C. M. (2025). Determinants of sibling relationships in the context of mental disorders. PLoS One.

Del Prete, C. M. (2025). Siblings of persons with disabilities: A systematic integrative review of the empirical literature. Clinical Child and Family Psychology Review.

Del Prete, C. M. (2023). Parentification, distress, and relationships with parents as factors shaping relationships in families with disability. Frontiers in Psychiatry.

Del Prete, C. M. (2022). An observational cross-sectional study of gender and disability as determinants of person-centered medicine in botulinum neurotoxin treatment of upper motoneuron syndrome. Toxins.

Del Prete, C. M. (2022). Brace treatment in adolescent idiopathic scoliosis: A rehabilitative point of view. International Journal of Environmental Research and Public Health.

Del Prete, C. M. (2021). Early botulinum toxin type A injection for post-stroke spasticity: A longitudinal cohort study. Toxins.

Del Prete, C. M. (2022). Efficacy of ultrasound-guided percutaneous lavage and biocompatible electrical neurostimulation in calcific rotator cuff tendinopathy. International Journal of Environmental Research and Public Health.

Del Prete, C. M. (2004). Conservative rehabilitative treatment of facial nerve injuries: A critical literature review. Europa Medicophysica.

Del Prete, C. M. (2002). Outcome research in adults with neurological disability. Europa Medicophysica.

Del Prete, C. M. (2001). Therapeutic water exercise in patients with hip arthroplasty. Europa Medicophysica.